Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foray Bioscience develops a proprietary biomanufacturing platform that uses advanced plant cell culture techniques—powered by predictive databases and machine learning—to produce high-value wood products (oils/resins), cellulose pulp for textiles/paper, seeds for reforestation efforts, and other plant-derived goods without cutting down trees. Their approach aims to dramatically accelerate production timelines versus traditional agriculture/forestry while supporting ecosystem restoration by reducing deforestation pressures. The company recently raised $3M in seed funding to expand its R&D team and capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foray Bioscience.